The cardiomyopathy surveillance recommendations have been published:

Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, Nathan PC, Tissing W, Shankar S, Sieswerda E, Skinner R, Steinberger J, van Dalen EC, van der Pal HJ, Wallace WH, Levitt G, Kremer LCM (2015), Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. The Lancet Oncology, Volume 16, Issue 3, Pages e123 – e136, doi:10.1016/S1470-2045(14)70409-7